Meet Our Team

Carles is the Senior Director of Sales & Marketing at Curapath. He holds a PhD in Organic Chemistry and an M.Sc. in Applied and Pharmacological Chemistry, bringing more than 10 years of experience in nanomedicine, drug delivery, and advanced therapeutics.

Since joining Curapath in 2018, he has played a key role in expanding the company’s expertise in non-viral delivery technologies and strengthening its position in the drug delivery and nanomedicine space. With more than 15 peer-reviewed publications and over 5 patents, Carles combines scientific expertise with a strong commercial mindset to support innovative therapeutic programs and identify new market opportunities.

Having worked closely with biotech and pharmaceutical companies across programs from early development to clinical stages, Carles brings a unique understanding of both the scientific and commercial aspects of drug development, helping clients define effective development and manufacturing strategies.

In his current role, Carles leads Curapath’s commercial activities, focusing on business growth, strategic partnerships, and customer engagement across the biotechnology and pharmaceutical sectors.

José María is the Supply Chain & Procurement Director at Curapath. He brings more than 15 years of international experience in operations, supply chain management, and industrial project execution within the pharmaceutical and technology sectors.

Before joining Curapath, he held several leadership roles at Nice Tech, including Head of Operations and Head of Supply Chain, managing facilities across the Philippines, Morocco, Mexico, and Spain. Earlier in his career, he led large-scale industrial plant projects and served as Project Manager at AKO and later at SURIS.

José María holds an Executive MBA from ESADE Business School and has completed executive education at HEC Paris. His combined expertise in engineering, procurement, and executive leadership enables him to drive supply chain innovation and support Curapath’s mission to deliver cutting-edge non-viral delivery technologies.

Ángeles is Finance Director at Curapath. She holds a Bachelor’s Degree in Economic and Business Sciences from the University of Valencia and brings more than 30 years of experience as Head of Finance in national and international companies across the technology, automotive, automation, and import-export sectors, as well as in financial consulting.

Since joining Curapath in 2021, she has been instrumental in developing the Finance Department, implementing new financial and accounting processes and procedures to strengthen the company’s structure.

With solid expertise in financial reporting, forecasting, treasury management, taxation, auditing, and management control, Ángeles combines strong analytical skills with a collaborative approach. Her strategic and results-driven mindset ensures sound financial management, enabling Curapath to sustain growth while meeting both operational and long-term business objectives.

Jose is Operations Director at Curapath. Jose brings over 15 years of experience in the pharmaceutical field, working in Operations and Quality. He is a pharmacist with a Master's degree in Pharmaceutical Industry and a Master's in Biomedical Biotechnology.

Before joining Curapath, he spent over five years as an inspector for the Spanish Health Authorities assessing the GMP compliance of commercial Drug Substances and Drug Products manufacturers.

Since he joined Curapath, he has led the creation and implementation of the quality system from scratch, organized the manufacturing departments according to GMP standards, and led the construction of Curapath’s GMP facilities for both Drug Substances and Sterile Drug Products.

Sergio is the Senior Director of Manufacturing Science & Technology (MSAT) at Curapath. He is a chemist by training and holds a Ph.D. in Organic Chemistry.

With more than 15 years of experience in pharmaceutical development and manufacturing, Sergio has led the development, validation, scale-up, and technology transfer of manufacturing processes and analytical methods for novel active pharmaceutical ingredients (APIs) and drug products.

Throughout his career, he has developed extensive expertise in the manufacture of radiopharmaceuticals, polymer-based therapeutics, and other advanced pharmaceutical products, supporting their progression from early development through clinical and commercial stages.

Since joining Curapath in 2016, Sergio has held roles of increasing responsibility and has been instrumental in establishing the company’s Quality Control capabilities, Operations, and technical operations infrastructure.

In his current role, Sergio leads MSAT activities across client programs, providing strategic and technical oversight for process development, scale-up, technology transfer, GMP manufacturing, process characterization, validation, and commercial readiness. He works closely with clients to ensure the successful translation of innovative therapies from early feasibility through late-stage development and commercialization.

Aroa is a chemist by training and holds a PhD in Biochemistry and Biotechnology. She brings more than 10 years of experience in drug delivery and polymer science. She joined Curapath in 2021 and currently serves as Director of Development.

Aroa did her PhD at the CIPF in Valencia at the Polymer Therapeutics Lab self-funded with a fellowship from the national scheme. Then, she moved to the Molecular Bionics Lab at UCL London for a postdoctoral experience, first with the competitive Newton International Fellowship from the Royal Society of the UK, and later with a Marie Curie Fellowship from the European Commission.

Her scientific background has provided her with vast experience in project management, supervisory responsibilities, and successful grant applications. She counts more than 30 publications, including patents and research monographs.

Since joining Curapath through the Torres Quevedo Program from the Spanish Ministry of Science, Aroa has played a key role in strengthening and expanding the company’s development capabilities, supporting the advancement of innovative drug delivery technologies and client programs.

Juan José is the Director of CMC Program Management at Curapath. He holds an M.Sc. in Supramolecular Chemistry and a Ph.D. in Biochemistry and Biomedicine, with more than 10 years of experience in nanomedicine and advanced drug delivery systems.

Throughout his career, he has contributed to the development of innovative therapeutics, spanning formulation development, characterization, preclinical evaluation, and CMC strategy, and has authored more than 10 peer-reviewed publications.

Since joining Curapath in 2019, Juan José has led the execution of complex development programs from early research through clinical manufacturing and regulatory submissions. His multidisciplinary background enables him to effectively coordinate development, manufacturing, analytical, quality, and regulatory activities across the product lifecycle.

In his current role, Juan José leads CMC program management activities, supporting clients in the development and advancement of innovative therapies from preclinical stages through clinical development.